Abstract
Objectives
To explore associations between inflammatory endotypes and clinical presentations in CRS. To investigate the value of secretions myeloperoxidase (MPO) and eosinophilic cationic protein (ECP) detections in the diagnosis of endotypes of chronic rhinosinusitis (CRS), so as to provide guidance for the clinical application of MPO and ECP detection in secretions.
Methods
We collected clinical symptom scores from patients with CRS and examined the differences between endotypes in clinical features. Patients’ nasal secretions and polyps (or middle turbinate for control) were collected and their NEU number, EOS%, MPO and ECP levels were measured. Correlation analysis was performed for these biomarkers in secretions and tissues, respectively. Receiver operating characteristic curves were used to assess the predictive potential of the biomarkers mentioned above in nasal secretions.
Results
Patients with Eos+Neu+ and Eos+Neu−CRS scored highest in most clinical symptom scores, while Eos−Neu+ and Eos−Neu−CRS scored lowest. Correlation analysis showed that tissues NEU number was correlated with NEU number and MPO level in nasal secretions (R = 0.4088; 0.6613); tissues EOS % was correlated with EOS% and ECP level in nasal secretions (R = 0.2344; 0.5774). To diagnose Neu+CRS, the highest area under the curve (AUC) (0.8961) was determined for MPO in secretions; the highest AUC (0.7400) was determined for NEU number in secretions. To diagnose Eos+Neu−CRS from Eos−Neu−CRS in Neu−CRS, the highest AUC (0.8801) was determined for ECP in secretions.
Conclusions
Clinical presentations are directly associated with CRS endotypes. Measurement of MPO and ECP in nasal secretions is useful for the endotypes diagnosis of CRS.
Similar content being viewed by others
Availability of data and materials
Data can be made available on request.
References
Bachert C, Marple B, Schlosser RJ et al (2020) Adult chronic rhinosinusitis. Nat Rev Dis Primers 6(1):86
Khan A, Vandeplas G, Huynh T et al (2019) The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhinology 57(1):32–42
Van Zele T, Claeys S, Gevaert P et al (2006) Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 61(11):1280–1289
Bachert C, Zhang N, Hellings PW et al (2018) Endotype-driven care pathways in patients with chronic rhinosinusitis. J Allergy Clin Immunol 141(5):1543–1551
Tomassen P, Vandeplas G, Van Zele T et al (2016) Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol 137(5):1449–1456
Wang X, Zhang N, Bo M et al (2016) Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol 138(5):1344–1353
Stevens WW, Peters AT, Tan BK et al (2019) Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Allergy Clin Immunol Pract 7(8):2812–2820
Tan BK, Klingler AI, Poposki JA et al (2017) Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois. J Allergy Clin Immunol 139(2):699–703
Tyler MA, Russell CB, Smith DE et al (2017) Large-scale gene expression profiling reveals distinct type 2 inflammatory patterns in chronic rhinosinusitis subtypes. J Allergy Clin Immunol 139(3):1061–1064
Kim DW, Eun KM, Roh EY et al (2019) Chronic Rhinosinusitis without nasal polyps in asian patients shows mixed inflammatory patterns and neutrophil-related disease severity. Mediators Inflamm 2019:7138643
Liao B, Liu JX, Li ZY et al (2018) Multidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes. Allergy 73(7):1459–1469
Lou H, Meng Y, Piao Y et al (2016) Cellular phenotyping of chronic rhinosinusitis with nasal polyps. Rhinology 54(2):150–159
Wei Y, Zhang J, Wu X et al (2020) Activated pyrin domain containing 3 (NLRP3) inflammasome in neutrophilic chronic rhinosinusitis with nasal polyps (CRSwNP). J Allergy Clin Immunol 145(3):1002–1005
Aratani Y (2018) Myeloperoxidase: its role for host defense, inflammation, and neutrophil function. Arch Biochem Biophys 640:47–52
Keatings VM, Barnes PJ (1997) Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 155(2):449–453
Nauseef WM (2014) Myeloperoxidase in human neutrophil host defence. Cell Microbiol 16(8):1146–1155
Klebanoff SJ, Kettle AJ, Rosen H et al (2013) Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J Leukoc Biol 93(2):185–198
Hampton MB, Kettle AJ, Winterbourn CC (1998) Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92(9):3007–3017
Marcucci F, Sensi LG, Migali E et al (2001) Eosinophil cationic protein and specific IgE in serum and nasal mucosa of patients with grass-pollen-allergic rhinitis and asthma. Allergy 56(3):231–236
Pipkorn U, Karlsson G, Enerback L (1988) The cellular response of the human allergic mucosa to natural allergen exposure. J Allergy Clin Immunol 82(6):1046–1054
Zhang N, Van Zele T, Perez-Novo C et al (2008) Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 122(5):961–968
Bachert C, Zhang N, Holtappels G et al (2010) Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol 126(5):962–968
Fokkens WJ, Lund VJ, Hopkins C et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58(Suppl S29):1–464
Kuang FL (2020) Approach to patients with eosinophilia. Med Clin N Am 104(1):1–14
Chen J, Zhou Y, Zhang L et al (2017) Individualized treatment of allergic rhinitis according to nasal cytology. Allergy Asthma Immunol Res 9(5):403–409
Xi Y, Deng YQ, Li HD et al (2022) Diagnostic value of a novel eosinophil cationic protein-myeloperoxidase test paper before and after treatment for allergic rhinitis. J Asthma Allergy 15:1005–1019
Yao Y, Yang C, Yi X et al (2020) Comparative analysis of inflammatory signature profiles in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyposis. Biosci Rep 40(2):BSR20193101. https://doi.org/10.1042/BSR20193101
Cao PP, Li HB, Wang BF et al (2009) Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 124(3):478–484
Jang YJ, Lim JY, Kim S et al (2018) Enhanced interferon-beta response contributes to eosinophilic chronic rhinosinusitis. Front Immunol 9:2330
Lin D, Lin H, Xiong X (2014) Expression and role of BAG-1 in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps. Inflammation 37(6):1912–1918
Ikeda K, Shiozawa A, Ono N et al (2013) Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil[J]. Laryngoscope 123(11):E1–E9
Shi LL, Xiong P, Zhang L et al (2013) Features of airway remodeling in different types of Chinese chronic rhinosinusitis are associated with inflammation patterns. Allergy 68(1):101–109
Pothoven KL, Norton JE, Suh LA et al (2017) Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease. J Allergy Clin Immunol 139(6):1966–1978
Khan MA, Ali ZS, Sweezey N et al (2019) Progression of cystic fibrosis lung disease from childhood to adulthood: neutrophils, neutrophil extracellular trap (NET) formation, and NET degradation. Genes (Basel) 10(3):183. https://doi.org/10.3390/genes10030183
Poposki JA, Klingler AI, Stevens WW et al (2022) Elevation of activated neutrophils in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 149(5):1666–1674
Chitsuthipakorn W, Seresirikachorn K, Sommer DD et al (2018) Endotypes of chronic rhinosinusitis across ancestry and geographic regions. Curr Allergy Asthma Rep 18(9):46
Sun DI, Joo YH, Auo HJ et al (2009) Clinical significance of eosinophilic cationic protein levels in nasal secretions of patients with nasal polyposis. Eur Arch Otorhinolaryngol 266(7):981–986
Kim KS, Won HR, Park CY et al (2013) Analyzing serum eosinophil cationic protein in the clinical assessment of chronic rhinosinusitis. Am J Rhinol Allergy 27(3):e75–e80
Kramer MF, Ostertag P, Pfrogner E et al (2000) Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis. Laryngoscope 110(6):1056–1062
Ruan JW, Zhao JF, Li XL et al (2021) Characterizing the neutrophilic inflammation in chronic rhinosinusitis with nasal polyps. Front Cell Dev Biol 9:793073
Succar EF, Li P, Ely KA et al (2020) Neutrophils are underrecognized contributors to inflammatory burden and quality of life in chronic rhinosinusitis. Allergy 75(3):713–716
Lou H, Zhang N, Bachert C et al (2018) Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement. Int Forum Allergy Rhinol 8(11):1218–1225
Lou H, Meng Y, Piao Y et al (2015) Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population. Am J Rhinol Allergy 29(5):350–356
Delemarre T, Holtappels G, De Ruyck N et al (2021) A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 147(1):179–188
Ochkur SI, Kim JD, Protheroe CA et al (2012) A sensitive high throughput ELISA for human eosinophil peroxidase: a specific assay to quantify eosinophil degranulation from patient-derived sources. J Immunol Methods 384(1–2):10–20
Monteseirin J, Vega A (2008) Eosinophil cationic protein is not only a distinctive eosinophil protein. Thorax 63(2):185
Abu-Ghazaleh RI, Dunnette SL, Loegering DA et al (1992) Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol 52(6):611–618
Gurrola JN, Borish L (2017) Chronic rhinosinusitis: endotypes, biomarkers, and treatment response. J Allergy Clin Immunol 140(6):1499–1508
Wen W, Liu W, Zhang L et al (2012) Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. J Allergy Clin Immunol 129(6):1522–1528
Van Zele T, Gevaert P, Holtappels G et al (2010) Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 125(5):1069–1076
Zheng W, Warner R, Ruggeri R et al (2015) PF-1355, a mechanism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritis. J Pharmacol Exp Ther 353(2):288–298
Lu PC, Lee TJ, Huang CC et al (2021) Serum eosinophil cationic protein: a prognostic factor for early postoperative recurrence of nasal polyps. Int Forum Allergy Rhinol 11(4):766–772
Acknowledgements
The authors thank all participants in this study for their enthusiastic cooperation.
Funding
This research was supported by the National Natural Science Foundation of China (no. 82201250), Natural Science Foundation of Hubei Province (no. 2021CFB125) and Wuhan Dabai Xiaobai Technology Co., Ltd., China (2021HX0027).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jin, J., Guo, B., Zhang, W. et al. Diagnostic value of myeloperoxidase and eosinophil cationic protein in nasal secretions for endotypes of chronic rhinosinusitis. Eur Arch Otorhinolaryngol 280, 3707–3720 (2023). https://doi.org/10.1007/s00405-023-07903-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-023-07903-3